[Effectiveness of sequential vs concurrent chemoradiation or radiation alone in the adjuvant treatment of cervical cancer after hysterectomy].
作者信息
Schiller Kilian, Combs Stephanie E
机构信息
Klinik und Poliklinik für RadioOnkologie und Strahlentherapie, TU München, München, Deutschland.
Institut für Innovative Radiotherapie (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München (HMGU), München, Deutschland.
出版信息
Strahlenther Onkol. 2021 Aug;197(8):746-748. doi: 10.1007/s00066-021-01796-z. Epub 2021 May 30.
Abstract
摘要
相似文献
1
[Effectiveness of sequential vs concurrent chemoradiation or radiation alone in the adjuvant treatment of cervical cancer after hysterectomy].[子宫切除术后序贯与同步放化疗或单纯放疗在宫颈癌辅助治疗中的疗效]
Strahlenther Onkol. 2021 Aug;197(8):746-748. doi: 10.1007/s00066-021-01796-z. Epub 2021 May 30.
2
Survival impact of adjuvant concurrent chemoradiotherapy after radical hysterectomy in FIGO stage IIIC1 cervical adenocarcinoma.根治性子宫切除术联合辅助放化疗对 FIGO 分期 IIIC1 期宫颈腺癌患者生存的影响。
Int J Clin Oncol. 2021 Jul;26(7):1322-1329. doi: 10.1007/s10147-021-01904-0. Epub 2021 Apr 6.
3
Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.根治性子宫切除术治疗中危早期宫颈癌的辅助治疗作用。
Int J Gynecol Cancer. 2021 Jan;31(1):52-58. doi: 10.1136/ijgc-2020-001974. Epub 2020 Dec 10.
4
Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy.根治性子宫切除术后伴有淋巴结转移的早期宫颈癌患者的巩固化疗。
Int J Gynecol Cancer. 2020 May;30(5):602-606. doi: 10.1136/ijgc-2019-000690. Epub 2020 Mar 9.
5
Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery.根治性放化疗后辅助子宫切除术治疗 IB2 期和 IIA2 期宫颈癌：开放式手术与微创手术并发症的回顾性比较。
Radiat Oncol. 2021 Jun 29;16(1):123. doi: 10.1186/s13014-021-01843-0.
6
The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.2018年国际妇产科联盟（FIGO）IB2期宫颈癌患者行根治性子宫切除术后的最佳肿瘤大小上限。
Int J Gynecol Cancer. 2020 Jul;30(7):975-980. doi: 10.1136/ijgc-2020-001271. Epub 2020 May 28.
7
A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082).一项比较术后宫颈癌辅助化疗与同期放化疗的随机 III 期临床试验：日本妇科肿瘤学组研究（JGOG1082）。
Int J Gynecol Cancer. 2021 Apr;31(4):623-626. doi: 10.1136/ijgc-2020-002344. Epub 2021 Mar 4.
8
Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma.局部晚期宫颈腺癌同步放化疗后筋膜外子宫切除术
J Gynecol Oncol. 2016 Jul;27(4):e40. doi: 10.3802/jgo.2016.27.e40. Epub 2016 Apr 18.
9
Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.2003年至2012年国际妇产科联盟IIb期宫颈癌的治疗结果：治疗与预后评估：一项回顾性研究
Int J Gynecol Cancer. 2015 Jun;25(5):910-8. doi: 10.1097/IGC.0000000000000430.
10
Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database.术前放化疗联合子宫切除术治疗宫颈癌：大型医院数据库中的治疗模式和生存情况。
J Gynecol Oncol. 2019 May;30(3):e41. doi: 10.3802/jgo.2019.30.e41.
引用本文的文献
1
Neoadjuvant radiochemotherapy in patients with high-risk locally advanced cervical cancer-results of a clinical series.高危局部晚期宫颈癌患者的新辅助放化疗——一项临床系列研究结果
Strahlenther Onkol. 2025 May;201(5):537-545. doi: 10.1007/s00066-024-02340-5. Epub 2025 Jan 8.
2
Efficacy and Safety Analysis of Recombinant Human Endostatin (Endostar) Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer: A 2-Center Retrospective Study.重组人血管内皮抑制素（恩度）联合放化疗治疗局部晚期宫颈癌的疗效及安全性分析：一项 2 中心回顾性研究。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241263026. doi: 10.1177/15330338241263026.
本文引用的文献
1
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.含顺铂的四种双联方案用于IVB期、复发性或持续性宫颈癌的III期试验：一项妇科肿瘤学组研究
J Clin Oncol. 2009 Oct 1;27(28):4649-55. doi: 10.1200/JCO.2009.21.8909. Epub 2009 Aug 31.
2
Chemotherapy for advanced, recurrent, and metastatic cervical cancer.晚期、复发性和转移性宫颈癌的化疗。
J Natl Compr Canc Netw. 2008 Jan;6(1):53-7. doi: 10.6004/jnccn.2008.0006.
3
Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial.根治性子宫切除术后放疗与化疗应用的再思考：一项妇科肿瘤学组/西南肿瘤学组/放射治疗肿瘤学组试验的临床病理分析
Gynecol Oncol. 2005 Mar;96(3):721-8. doi: 10.1016/j.ygyno.2004.11.007.
4
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.在高危早期宫颈癌根治术后，同步化疗与盆腔放疗联合与单纯盆腔放疗作为辅助治疗的比较。
J Clin Oncol. 2000 Apr;18(8):1606-13. doi: 10.1200/JCO.2000.18.8.1606.
5
A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study.一项针对根治性子宫切除术后及盆腔淋巴结清扫术后选定的IB期宫颈癌患者，比较盆腔放射治疗与不进行进一步治疗的随机试验：妇科肿瘤学组研究。
Gynecol Oncol. 1999 May;73(2):177-83. doi: 10.1006/gyno.1999.5387.
Zotero 插件